Silicon Agent Generates Hydrogen to Heal Pressure Sores in Mice

Authors
Journal
Biomedicines
Year
DOI
10.3390/biomedicines13102475
Study Type
Mouse
Outcome
Positive
Peer Reviewed
Yes
Country
Japan
Health Condition
Pressure Ulcers
Body System
Integumentary

TL;DR

A silicon-based oral agent that produces hydrogen reduced ulcer size, inflammation, and oxidative stress in mice with pressure ulcers.

Key Finding

Mice fed a silicon-based hydrogen-generating agent showed significantly smaller pressure ulcers and faster healing compared to control mice, with reduced inflammation and oxidative stress in the wound tissue.

Summary

Researchers tested a silicon-based substance that generates hydrogen gas in mice with pressure ulcers (wounds caused by prolonged skin compression). Mice that consumed this substance in their food showed faster healing, smaller ulcer areas, and reduced inflammation and cell damage compared to mice on a normal diet. The results suggest this approach may offer a practical way to deliver hydrogen's antioxidant benefits.

Practical Takeaway

This early-stage animal study suggests a silicon-based hydrogen source may help with pressure ulcer healing, but human studies are needed before any conclusions can be drawn for people. The findings are limited to mice and do not yet demonstrate safety or effectiveness in humans.

Abstract

Objectives: As a known antioxidant, hydrogen has been useful for treating pressure ulcers. However, conventional methods of hydrogen administration have limitations with regard to dosage and continuity of hydrogen intake. This study evaluated the efficacy of a novel Si-containing agent that can generate substantial quantities of hydrogen to treat pressure ulcers in an in vivo mouse model. Methods: The back skin and subcutaneous tissue of mice were compressed with magnets for 12 h. Changes in the ulcer area after release of compression, histological findings, degree of apoptosis, and expression levels for oxidative stress markers and inflammation-related cytokines were compared between mice fed a normal diet (control group) and those fed a 2.5 wt% Si-based diet (Si group). Results: The Si group had a significantly smaller ulcer area and shorter healing period than the control group. Moreover, inflammatory responses, apoptotic activity, and oxidative stress within the ulcer tissue were suppressed significantly in the Si group. Conclusions: Oral intake of the Si-based agent can potentially treat and prevent pressure ulcers by regulating apoptosis, oxidative stress, and inflammatory responses.